article thumbnail

PBMs and insurers want your prescription money

World of DTC Marketing

For many, these coupons represent the difference between filling a prescription and going without lifesaving care, but there is a lot more here than just a co-pay coupon. In 2021 pharma provided a staggering $204 billion in price concessions for brand-name medicines to PBMs. These pricing scams hurt patients as well.

Insurance 226
article thumbnail

Sorry, the Inflation Bill won’t lower healthcare costs

World of DTC Marketing

It’s no wonder that voters consistently rank bringing down prescription drug prices and other measures to reduce the cost of care as among Congress’ top priorities. Congress rightly chose to negioate drug prices for Medicare, but prescription drugs are only 10-12% of every healthcare dollar we spend. As the U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

7 Pharmaceutical Industry Trends for your 2021 Marketing Strategy

Silver Line CRM

Reading time: 7 minutes As we all look to 2021, what are the pharmaceutical industry trends to build into your life sciences marketing strategy? But today, the need to satisfy patients, providers, payers, regulatory agencies, and shareholders alike — while staying ahead of the competition — takes the right technologies at the right time. .

article thumbnail

US legislative update: takeaways for European pharma

European Pharmaceutical Review

In the current US Congressional session, Congress has focused heavily on legislation directed at reducing prescription drug prices. Three pending bills introduced in 2021 include strategies for reducing delay caused by Citizen Petitions. Senate Bill 562 (S.

article thumbnail

Pharma says VPAS clawback jeopardises UK sector

pharmaphorum

billion in 2021 to £1.8 Next year we must start again with a clean sheet of paper to agree on what an internationally competitive scheme looks like.” “The NHS runs on generic and biosimilar medicines, with four out of five prescriptions being filled by off-patent products,” said the BGMA’s CEO Mark Samuels.

Pharma 70
article thumbnail

Pharma Injecting Life into Digital Health Amidst Funding Downturn

MedCity News

digital health sector plummeted to $15 billion from more than $29 billion in 2021, according to Rock Health. billion in 2021. Trial access equity and inclusivity are important considerations for sponsors given the results of a 2021 analysis of U.S. Venture capital and other startup investment in the U.S. digital health at $17.7

Pharma 110
article thumbnail

Nine for 2023, part three: thriving or surviving?

pharmaphorum

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.